Log in to search using one of your social media accounts:

 

Johnson & Johnson wins California lawsuit claiming asbestos in talc caused cancer
(Reuters) - A California jury on Thursday ruled in favor of Johnson& Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company's talc-based products including J&J's Baby Powder. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Charity appoints expert lung cancer nurse for North West
A new mesothelioma clinical nurse specialist has been appointed to support the high number of patients with the condition across Merseyside and Cheshire. (Source: Nursing Times)
Source: Nursing Times - November 15, 2017 Category: Nursing Source Type: news

NYPD Honors Flores for Work with Asbestos-Related Diseases
New York City Police Commissioner James O’Neill recently appointed mesothelioma specialist Dr. Raja Flores to the Society of Honorary Police Surgeons. The prestigious appointment stems from Flores’ continued, long-running service to so many first responders — particularly policemen and firemen from the 9/11 World Trade Center (WTC) terrorist attack in 2001. Although Flores has received many honors throughout his medical career, this one might be his most appreciated. “This is a huge honor for me,” Flores told Asbsetos.com. “I come from a family of cops. Police work is in my blood. My gra...
Source: Asbestos and Mesothelioma News - November 13, 2017 Category: Environmental Health Authors: Daniel King Tags: 9/11 9/11-related cancer James O’Neill Mount Sinai Hospital New York City Police Commissioner NYPD Raja Flores Society of Honorary Police Surgeons twin towers World Trade Center World Trade Center Health Program Source Type: news

Senate Introduces Latest Attempt to Ban Asbestos
U.S. Sen. Jeff Merkley, D-Ore., introduced legislation in Congress this week that would effectively ban all use of asbestos. The Alan Reinstein Ban Asbestos Now Act of 2017 is the sixth legislative attempt to ban the toxic substance in the last 20 years. All previous bills failed to gain enough support. While the 2016 Toxic Substances Control Act (TSCA) already includes asbestos on its top ten chemicals for risk review by the Environmental Protection Agency (EPA), Merkley’s legislation could speed the process considerably. What Would the Bill to Ban Asbestos Do? According to Merkley’s congressional office, the ...
Source: Asbestos and Mesothelioma News - November 8, 2017 Category: Environmental Health Authors: Daniel King Tags: Alan Reinstein Ban Asbestos Now Act asbestos ban Cory Booker environmental protection agency EPA Jeff Merkley Jon Tester Raja Flores Steve Daines Toxic Substances Control Act TSCA u.s. congress Source Type: news

Mesothelioma Researcher May Help Identify Best Candidates for...
Italian scientists say genetic testing for gene expression may be the key to more effective mesothelioma treatment.(PRWeb November 08, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14887255.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 8, 2017 Category: Pharmaceuticals Source Type: news

New Limits Threaten EPA ’s Asbestos Review
After pushback from the chemical industry, President Donald Trump’s administration is scaling back a congressionally mandated review of asbestos and other deadly chemicals. Toxic minerals in widespread use will be excluded from the revamped Toxic Substances Control Act (TSCA), which last December included asbestos among the top 10 dangerous chemicals the Environmental Protection Agency (EPA) must review. Reducing the scope of the review will potentially leave millions of tons of asbestos and other toxic substances in homes and businesses. The Trump administration reportedly wants to limit risk evaluations of the top ...
Source: Asbestos and Mesothelioma News - November 6, 2017 Category: Environmental Health Authors: Matt Mauney Tags: American Chemistry Council American Cleaning Institute American Petroleum Institute Asbestos Disease Awareness Organization asbestos exposure firefighters asbestos imports U.S. asbestos laws us Centers for Disease Control and Prevention Di Source Type: news

Subset of carbon nanotubes poses cancer risk similar to asbestos in mice
(Cell Press) Researchers have shown for the first time in mice that long and thin nanomaterials called carbon nanotubes may have the same carcinogenic effect as asbestos: they can induce the formation of mesothelioma. The findings were observed in 10 percent -- 25 percent of the 32 animals included in the study, which has not yet been replicated in humans. The work appears Nov. 6 in Current Biology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 6, 2017 Category: Cancer & Oncology Source Type: news

Review Shows Bevacizumab Has Gained Momentum for Mesothelioma...
The VEGF inhibitor is now part of the standard treatment for pleural mesothelioma in France and a recognized first-line option for American clinicians.(PRWeb November 06, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14884392.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 6, 2017 Category: Pharmaceuticals Source Type: news

Koch Industries Puts Bestwall Unit, A Small Player In Asbestos, In Bankruptcy
Bestwall said joint compound in total never amounted to more than 1.5 percent of asbestos-containing products sold in the U.S., yet the company is now named in 70-80 percent of all lawsuits over mesothelioma, a cancer that can be caused by asbestos exposure. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 3, 2017 Category: Pharmaceuticals Authors: Legal Newsline, Contributor Source Type: news

FDA Cautions Cancer Patients About Medical Marijuana
The U.S. Food and Drug Administration (FDA) issued a stern warning Wednesday to companies marketing medical marijuana to cure or inhibit cancer — including mesothelioma — and cautioned patients about unsubstantiated claims. The FDA sent warning letters to four particular companies, citing deceptive marketing in violation of the Federal Food, Drug and Cosmetic Act. “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer,” said FDA Commissioner Scott Gottlieb in a press release Wednesday. “And we&rsqu...
Source: Asbestos and Mesothelioma News - November 2, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: FDA marijuana warning marijuana for cancer medical marijuana for cancer Source Type: news

New Evidence Points to Potential of FGFR Inhibitors in Malignant...
Research suggests that some mesothelioma patients may be especially sensitive to drugs that inhibit this crucial signaling pathway.(PRWeb November 02, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14874826.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 2, 2017 Category: Pharmaceuticals Source Type: news

New Study Shows Improved Peritoneal Mesothelioma Survival
Patients with malignant peritoneal mesothelioma who completed a novel, two-stage cytoreduction and intraperitoneal chemotherapy regimen had a median overall survival of 6.65 years. Almost 30 percent of those patients had a survival estimate of more than 10 years after the second stage of treatment, according to a study published recently in the Annals of Surgical Oncology. The study involved 113 patients from New York-Presbyterian Hospital/Columbia University Medical Center. Researchers demonstrated the therapeutic advances concerning this once unbeatable cancer. While progress has been slow in improving current pleural me...
Source: Asbestos and Mesothelioma News - October 31, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: Columbia University Medical Center Dr. Michael Kluger Dr. Paul Sugarbaker HIPEC for peritoneal mesothelioma New York-Presbyterian Hospital peritoneal mesothelioma treatment Source Type: news

NovoCure rises on Q3 EPS, sales beat
Shares in Novocure (NSDQ:NVCR) are on the rise today after the medical device maker topped revenue and losses-per-share expectations on Wall Street with its 3rd quarter earnings results. The St. Helier, N.J.-based company posted losses of $11.5 million, or 13¢ per share, on sales of $50.1 million for the 3 months ended September 30, seeing losses on the bottom-line shrink 65.8% while sales grew 131.2% compared with the same period during the previous fiscal year. Losses per share for the quarter came in under the 17¢ consensus on Wall Street, while sales beat the $43.6 million expectations on The Street. &ld...
Source: Mass Device - October 26, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup NovoCure Source Type: news

Lawsuit Claims Montana Is Not Enforcing Strict Asbestos Laws
A prominent, family-run asbestos-disposal company is suing the Montana Department of Environmental Quality (DEQ) for failing to enforce the state’s strict asbestos-waste laws. Doug Ingraham, corporate secretary at Ingraham Environmental Inc., believes the DEQ has been delinquent in its duty to protect citizens from unnecessary asbestos exposure. “It’s a simple case of the government maintaining the status quo and the public feeling protected, when actually, the government is failing them,” Ingraham told Asbestos.com. Ingraham said the DEQ has failed to apply the laws regarding asbestos abatement an...
Source: Asbestos and Mesothelioma News - October 26, 2017 Category: Environmental Health Authors: Matt Mauney Tags: asbestos abatement asbestos cleanup in libby montana asbestos landfill workers Asbestos laws in Montana asbestos lawsuit montana asbestos mines montana asbestos-disposal companies Butte-Silver Bow County DEQ Montana Doug Ingraham Ingra Source Type: news

Mesothelioma in Children
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 25, 2017 Category: General Medicine Source Type: news

Study Finds No Need to Expand Mesothelioma Palliative Care
Earlier palliative care for patients with pleural mesothelioma failed to improve quality of life or extend survival time in a recent study presented at the World Conference on Lung Cancer in Yokohama, Japan. The randomized control study took place in Australia and the United Kingdom, disputing an earlier recommendation by the American Society of Clinical Oncology (ASCO) that called for expanding palliative care for mesothelioma patients. “Blindly offering palliative care to all, that doesn’t appear to be a benefit,” Dr. Fraser Brims, study presenter from Curtin University in Perth, Australia, told Asbest...
Source: Asbestos and Mesothelioma News - October 23, 2017 Category: Environmental Health Authors: Matt Mauney Tags: American Society of Clinical Oncology Curtin University Dr. Fraser Brims epithelioid GHQ-12 Institute for Respiratory Health mesothelioma palliative care Perth Australia pleural mesothelioma quality-of-life variables Sir Charles Gardne Source Type: news

Figures reveal toll of asbestos in schools
Cuts to school funding have already cost lives and are risking many more, says UNISON today, as we head into next week’s European Health and Safety Week. A recent Freedom of Information request by the Joint Union Asbestos Committee revealed that at least 335 primary and secondary school teachers died of mesothelioma in Britain between 1980 and 2015, along with eight school secretaries, eight nursery nurses, 18 school midday assistants and 24 teaching assistants between 2003 and 2015. The statistics are recorded under occupation, so it is impossible to know how many former pupils have died too, although the American E...
Source: UNISON Health care news - October 19, 2017 Category: UK Health Authors: Amanda Kendal Tags: Article News asbestos european health and safety week h&s schools TUC national inspection day Source Type: news

Use of Off-Road Vehicles Tied to Asbestos Exposure
This study did not detail the number of ORV users who have experienced negative health outcomes. It did call for further study to determine prevalence of asbestos-related disease among ORV users. “Off-roading in areas with NOA (naturally occurring asbestos) or NOE (naturally occurring erionite) presents a nontraditional route of exposure that has not been sufficiently explored,” Wolfe wrote. “Public health initiatives should concentrate on increasing awareness of these risks.” Many Miles of Dangerous Trails Most asbestos exposure in the U.S. is work related. Occupational exposure is the primary caus...
Source: Asbestos and Mesothelioma News - October 18, 2017 Category: Environmental Health Authors: Walter Pacheco Tags: asbestos exposure environmental asbestos exposure mesothelioma off road vehicles secondhand asbestos exposure Source Type: news

RCT in Mesothelioma Finds No Benefit From Early Palliative Care RCT in Mesothelioma Finds No Benefit From Early Palliative Care
Although early palliative care was found to improve survival and quality of life in patients with lung cancer, no such benefits were seen in patients with mesothelioma.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Early palliative care provides no quality of life benefits for recently diagnosed MPM patients
(International Association for the Study of Lung Cancer) Early specialist palliative care for patients that were recently diagnosed with malignant pleural mesothelioma (MPM) does not impact quality of life (QOL) measures, according to research presented by Prof. Fraser Brims of Curtin University in Australia, at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) in Yokohama, Japan. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 16, 2017 Category: Cancer & Oncology Source Type: news

Aggressive Mesothelioma Surgery Benefits More Patients
Patients diagnosed with the worst cases of pleural mesothelioma could benefit the most from the aggressive surgery they often are denied, according to one recent study. The findings have raised questions about the restrictive surgery selection process at many specialty centers handling mesothelioma, the rare and aggressive cancer caused by asbestos exposure. “In some cases, patients are not being offered the aggressive surgery that could help their quality of life,” lead author Dr. Wickii Vigneswaran, mesothelioma specialist and chief of thoracic surgery at the Loyola University Medical Center, told Asbestos.co...
Source: Asbestos and Mesothelioma News - October 11, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Aggressive Mesothelioma Surgery asbestos exposure Dr. Wickii Vigneswaran epithelial mesothelioma epithelioid histology extrapleural pneumonectomy Loyola mesothelioma program Loyola University Medical Center mesothelioma Chicago mesotheli Source Type: news

Steve McQueen Film, PSA Brings Awareness to Mesothelioma
During the 90-minute feature documentary “Steve McQueen: American Icon,” audiences will reflect on the career of the “King of Cool” and discover the untold true story of the star’s late-in-life spiritual quest. They will also learn about mesothelioma — the rare cancer that killed McQueen at age 50 — and the dangers of asbestos. A public service announcement featuring Asbestos Disease Awareness Organization (ADAO) president and co-founder Linda Reinstein and Barbara McQueen, Steve’s widow, will air before encore screenings of the documentary on Oct. 10 and Oct. 19. Tickets a...
Source: Asbestos and Mesothelioma News - October 9, 2017 Category: Environmental Health Authors: Matt Mauney Tags: “Steve McQueen American Icon alternative cancer treatments Asbestos Disease Awareness Organization asbestos marines asbestos public service announcement Barbara McQueen Billy Grah born-again Christian dangers of asbestos Don Schoonover Source Type: news

Report: U.S. Imported 705 Metric Tons of Raw Asbestos in 2016
New data from the Department of Commerce and the U.S. International Trade Commission show the amount of raw asbestos imported to the U.S. nearly doubled from 2015 to 2016. The federal organizations estimate 705 metric tons of raw asbestos was imported last year — a significant and alarming increase from the reported 343 metric tons imported in 2015. Asbestos, a known carcinogen, is highly regulated but still used in the U.S., mainly by the chloralkali industry, which uses asbestos diaphragms in its chlorine manufacturing process. It is also found in imported clutches and brake linings, gaskets, cement corrugated sh...
Source: Asbestos and Mesothelioma News - October 6, 2017 Category: Environmental Health Authors: Matt Mauney Tags: American Chemistry Council American Cleaning Institute American Petroleum Institute asbestos ban United States asbestos bans worldwide asbestos brake linings asbestos cement asbestos corrugated sheets asbestos diaphragms Asbestos Disease Source Type: news

Eli Lilly defeats challenge to Alimta cancer drug patent
(Reuters) - A federal patent review board on Thursday rejected a challenge to a patent covering Eli Lilly and Co's Alimta drug to treat some lung cancers and mesothelioma. (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Johnson & Johnson Facing Asbestos Talcum Powder Lawsuits
Recently unsealed documents from a lawsuit against consumer goods and pharmaceutical giant Johnson & Johnson revealed the company knew for decades its talc products may have contained deadly asbestos fibers. The files show Johnson & Johnson was alerted of asbestos contamination risks in the early 1970s and trained employees to reassure the public its iconic baby powder products were never contaminated with the carcinogenic mineral. It is the latest chapter in the ongoing controversy over the alleged link between talcum powder and cancer. The lawsuit — filed on behalf of more than 50 women in St. Louis &mdash...
Source: Asbestos and Mesothelioma News - October 3, 2017 Category: Environmental Health Authors: Matt Mauney Tags: asbestos contamination asbestos in talcum powder asbestos lawsuits asbestos ovarian cancer Cashmere Bouquet talcum powder Colgate-Palmolive Dr. Barry Castleman Ernie Knewitz Johnson & Johnson Johnson & Johnson baby powder asbestos meso Source Type: news

Report Points to Value of New Mesothelioma Biomarker, According to...
Scientists say this molecule, linked to mesothelioma survival for the first time, could offer a new target for treatment.(PRWeb October 02, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14757636.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 2, 2017 Category: Pharmaceuticals Source Type: news

Mesothelioma Doctor Creates Preoperative Drink for Patients
Peritoneal mesothelioma specialist Dr. Charles Conway wants to make major surgery an easier, more manageable experience for his patients. His latest innovation — a preoperative, complex-carbohydrate beverage — should help considerably. Conway, director of surgical oncology at the Ridley-Tree Cancer Center in Santa Barbara, California, will begin offering patients the novel drink customized to speed recovery and lessen the risk of dangerous side effects. Conway designed SurgiStrong RecoverAid, a uniquely blended product to fill a void in the growing Enhanced Recovery After Surgery (ERAS) programs that have sprun...
Source: Asbestos and Mesothelioma News - September 29, 2017 Category: Environmental Health Authors: Matt Mauney Tags: citrulline Dr. Charles Conway mesothelioma surgery recovery mesothelioma surgery side effects Ochsner Cancer Center peritoneal mesothelioma preoperative complex-carbohydrate beverage Ridley-Tree Cancer Center Santa Barbara surgery-induce Source Type: news

Mesothelioma Survivor Leading Puerto Rico Recovery Efforts
Isabel De La Camara has forgotten about the mesothelioma cancer brewing inside her belly. Her concern for others — and her desire to help them — has overshadowed everything else in her life today. De La Camara, who lives in Central Florida, has hardly slept since Hurricane Maria ripped through her beloved Puerto Rico last week, carving a horrific path of destruction that left more than 3 million people without adequate food, water and other basic necessities. Some of her closest friends and family members are among those hit the hardest in San Juan, where she was born and raised, and one day — hopefully ...
Source: Asbestos and Mesothelioma News - September 28, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Change Your Community Christian Sharing Center cytoreduction surgery Hurricane Maria Hurricane Maria asbestos Isabel De La Camara mesothelioma treatment peritoneal mesothelioma Puerto Rico Puerto Rico asbestos exposure Puerto Rico care Source Type: news

Faith Guides Steve McQueen Through Mesothelioma Battle
Nicknamed “The King of Cool,” actor Steve McQueen seemed to have it all. Known for tough guy roles in “Bullitt,” “The Cincinnati Kid” and “The Towering Inferno,” McQueen became the highest-paid movie star in the world in 1974. He received an Academy Award nomination for his role in “The Sand Pebbles” and starred alongside all-star casts in “The Great Escape” and “The Magnificent Seven.” But off screen, McQueen’s life was just as fast as the renegade characters he played in films. Heavy drinking, prolific substance abuse and a public...
Source: Asbestos and Mesothelioma News - September 27, 2017 Category: Environmental Health Authors: Matt Mauney Tags: “Steve McQueen American Icon 1968 Ford Mustang Academy Award Asbestos Disease Awareness Organization asbestos military Barbara Leigh Barbara Minty McQueen Bible Billy Graham Bullitt Christianity Erwin Brothers Entertainment Fatho Source Type: news

Japanese Study Finds Post-Recurrence Treatment a Must for Long-Term...
Researchers say chemotherapy is often the best choice for optimizing the odds of surviving mesothelioma after radical surgery.(PRWeb September 26, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14730516.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 26, 2017 Category: Pharmaceuticals Source Type: news

Scientists Say Spice Compound May Shrink Aggressive Type of...
French researchers used curcumin to reduce the mass of sarcomatoid mesothelioma tumors in rats in just two weeks.(PRWeb September 25, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14730275.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 25, 2017 Category: Pharmaceuticals Source Type: news

Converting 30 Million Tons of Asbestos into Usable Chemicals
New details have emerged of a plan to remove 30 million tons of asbestos waste from the inactive 1,550-acre Eden-Lowell mine in Vermont. Solution: Move it to a proposed processing plant in Groveton, New Hampshire. The proposal is part of long-term cleanup plan that began in 2013, when officials with the Vermont Asbestos Group reached a settlement with the U.S. Environmental Protection Agency (EPA) and Vermont state officials. Under the agreement, Vermont Asbestos Group (VAG) will pay past and future cleanup costs and maintain the site, including protecting the public from potential environmental asbestos exposure. The ...
Source: Asbestos and Mesothelioma News - September 21, 2017 Category: Environmental Health Authors: Matt Mauney Tags: alternative uses of asbestos waste asbestos mine vermont asbestos runoff watersheds asbestos waste removal plan Belvidere Mountain Caledonian-Record Chrysotile asbestos converting asbestos into chemicals Eden-Lowell asbestos mine environ Source Type: news

Mesothelioma Clinical Trials Involve Gene Therapy
Treatment options for malignant mesothelioma may soon include customized gene therapy, according to thoracic surgeon and scientist Dr. Prasad Adusumilli at Memorial Sloan Kettering Cancer Center in New York. Gene therapy involves a laboratory reprogramming of a patient’s own T cells, which are a type of white blood cell, to recognize and destroy the cancer. The U.S. Food and Drug Administration (FDA) recently approved the first gene therapy specifically for pediatric leukemia, signaling the start of a new approach to cancer treatment in this country. The newly approved treatment is also known as chimeric antigen rece...
Source: Asbestos and Mesothelioma News - September 19, 2017 Category: Environmental Health Authors: Matt Mauney Tags: CAR T cell therapy checkpoint blockade chimeric antigen receptor T cell therapy Dr. Andy Haas Dr. Prasad Adusumilli Dr. Scott Gottlieb FDA Commissioner gene therapy cancer gene therapy for mesothelioma immunotherapy clinical trial mali Source Type: news

Trial Results Suggest Longer Mesothelioma Survival Possible with New...
Nintedanib boosted mesothelioma survival by more than five months in newly-published study.(PRWeb September 15, 2017)Read the full story at http://www.prweb.com/releases/2017/09/prweb14699696.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 15, 2017 Category: Pharmaceuticals Source Type: news

Rare genetic cause of peritoneal mesothelioma points to targeted therapy
(Brigham and Women's Hospital) BWH investigators have uncovered a new genetic cause of mesothelioma: a genetic rearrangement in the ALK gene, observed in three patients with peritoneal mesothelioma. Unlike previously known causes, this new discovery points to a potential therapeutic approach for those few patients whose tumors harbor the mutation. The team's findings are published in JAMA Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2017 Category: Cancer & Oncology Source Type: news

Rare Genetic Cause of Peritoneal Mesothelioma Points to Targeted Therapy
Genetic rearrangement in the ALK gene found in young women with mesothelioma may be targetable with FDA-approved drugs. (Source: BWH for Journalists)
Source: BWH for Journalists - September 14, 2017 Category: Research Source Type: news

Rare Genetic Cause of Peritoneal Mesothelioma Points to Targeted Therapy
Genetic rearrangement in the ALK gene found in young women with mesothelioma may be targetable with FDA-approved drugs. (Source: BWH News)
Source: BWH News - September 14, 2017 Category: Hospital Management Source Type: news

Global Mesothelioma Deaths Remain High Despite Poor Data
An estimated 38,400 people around the world will die this year from mesothelioma cancer, according to a report recently published in Occupational & Environmental Medicine. The estimation by the international peer-reviewed journal included 230 countries. Data used for the study came from the World Health Organization’s (WHO) Mortality Database and extrapolated information based on gender- and age-specific death rates. “The global burden of mesothelioma is real,” Dr. Ken Takahashi, director of Asbestos Diseases Research Institute, University of Sydney Gate 3, Australia, told Asbestos.com. “It is v...
Source: Asbestos and Mesothelioma News - September 13, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Asbestos Diseases Research Institute asbestos-related lung cancer Australia mesothelioma Bangladesh Dr. Christina Fitzmaurice Dr. Ken Takahashi Global Burden of Disease Mesothelioma death rate mesothelioma latency period mesothelioma uni Source Type: news

Deadly Asbestos Still Widely Used Around the World
Asbestos is a toxic material that is known to cause mesothelioma, a form of cancer. The material is still used across the globe exposing people to the resulting mesothelioma.By Brook SpencerWALLINGFORD, CT, US, Sep 8 2017 (IPS)The worldwide impact cancer has is well known. It is the second leading cause of death globally, and according to the World Health Organization, was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths are due to cancer and of those deaths approximately 70 percent occur in low and middle-income countries.Asbestos is a global problem that leads to real health risks – namely...
Source: IPS Inter Press Service - Health - September 8, 2017 Category: International Medicine & Public Health Authors: Brook Spencer Tags: Development & Aid Headlines Health Source Type: news

MD Anderson Retains Top Spot for Cancer Care
U.S. News & World Report ranked the MD Anderson Cancer Center in Houston the No. 1 cancer care hospital in America for the third consecutive year. MD Anderson has been a leader in the treatment of pleural mesothelioma, a contributing factor in maintaining its top billing on the rankings. Memorial Sloan Kettering in New York and Mayo Clinic in Rochester, Minnesota, were No. 2 and No. 3, respectively, in the 2017-18 Best Hospitals for Cancer  listing. U.S. News & World Report — a global authority in hospital care — has published the rankings annually for 28 years, helping patients make tough health c...
Source: Asbestos and Mesothelioma News - September 6, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Barnes-Jewis Hospital best mesothelioma cancer centers Cardiology Cleveland Clinic Gastroenterology H. Lee Moffitt Cancer Center and Research Institute heart surgery Johns Hopkins Massachusetts General Hospital Mayo Clinic Mayo Clinic- Source Type: news

Mesothelioma Patients Survive Longer with Trimodal Treatment
Pleural mesothelioma patients who undergo aggressive multimodal treatment live almost twice as long after diagnosis than those who do not, according to a recent extensive study. Researchers at MD Anderson Cancer Center in Texas found a combination of surgery, chemotherapy and radiation extended survival time significantly, regardless of disease histology or cancer stage. “We recommend that all patients with [malignant pleural mesothelioma] be evaluated by multidisciplinary teams that are experienced in the management of mesothelioma for consideration of surgery-based, multimodality treatment,” the authors wrote...
Source: Asbestos and Mesothelioma News - September 5, 2017 Category: Environmental Health Authors: Matt Mauney Tags: biphasic histology Dr. Anne Tsao Dr. Boris Sepesi Dr. Daniel Gomez Dr. David Rice Dr. Mark Berry epithelial mesothelioma Journal of Clinical Oncology md anderson cancer center mesothelioma chemotherapy mesothelioma mortality surgery Source Type: news

Bueno Earns NCI and DoD Grants for Mesothelioma Research
Raphael Bueno, MD, chief of the Division of Thoracic Surgery and the Fredric Levin Distinguished Chair in Thoracic Surgery and Lung Cancer Research, was recently awarded a five-year, $1.5 million renewal RO1 grant from the National Cancer Institute ( (Source: BWH News)
Source: BWH News - September 5, 2017 Category: Hospital Management Source Type: news

Upcoming Mesothelioma Symposium Filled with Hope
Discussions About Immunotherapy for Mesothelioma Cameron also will speak about engineering mesenchymal stem cells for immunotherapy. Clare Cameron, who is the executive director of the Pacific Mesothelioma Center (PMC) and not related to Dr. Robert Cameron, will talk about resources for research. Lein Hua-Feng, a nurse practitioner at PMC, will discuss the benefits of caregiver support groups. “The symposium will provide an unrivaled opportunity for both the medically savvy and general public, including mesothelioma patients,” Clare Cameron said. “You’ll hear about the most promising medical advance...
Source: Asbestos and Mesothelioma News - August 29, 2017 Category: Environmental Health Authors: Matt Mauney Tags: 7th annual International Symposium on Mesothelioma Angiogenesis Inhibition and Chemotherapy Arti Shukia Banaras Hindu University bap1 Center at the University Hospital of Siena clare cameron Dr. Anna Nowak Dr. Brian Cunniff Dr. David Sch Source Type: news

Trump ’ s Halt on Coal Mining Study Has Asbestos Implications
The U.S. Department of the Interior has ordered a halt to a study on the public health risks of mountaintop removal mining in Appalachia — an area ripe with natural asbestos deposits. A letter from the Interior Department on Monday directed the National Academies of Sciences, Engineering and Medicine to “cease all work” on the study, citing responsible spending of taxpayer dollars as the reason for the decision. The $1 million National Academies study began in 2016 and was expected to take two years to complete. It aimed to evaluate health risks of a common mining technique for people living near surfac...
Source: Asbestos and Mesothelioma News - August 24, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Appalachian Mountains arsenic asbestos exposure Appalachia asbestos exposure coal mining asbestosis coal mining Bill Price Central Appalachia coal mining Appalachia Donald Trump Environmental Health Perspectives Glenda Owens House Co Source Type: news

Alternative Medicine Alone Leads to Lower Cancer Survival
Cancer patients who opt for alternative therapy instead of conventional medicine significantly decrease their chances of survival, according to researchers at Yale School of Medicine. Although the popularity of alternative medicine continues to grow, a recent study published in the Journal of the National Cancer Institute found survival rates significantly reduced for those who use it as first-line therapy. Conventional cancer treatments — chemotherapy, surgery and radiation — still produce a much better chance of survival. Mesothelioma was not included in the study, but the findings are relevant to this rare ...
Source: Asbestos and Mesothelioma News - August 23, 2017 Category: Environmental Health Authors: Matt Mauney Tags: acupuncture cancer Alternative medicine alternative mesothelioma treatment alternative therapy survival alternative vs conventional medicine breast cancer colon cancer Conventional cancer treatments Dr. David Gorski Dr. Skyler Johnson Source Type: news

Nearly One-Third of Mesothelioma Patients Remain Untreated
A new report from the National Cancer Institute (NCI) shows between 20 and 30 percent of malignant mesothelioma patients do not receive any cancer treatment. The study, “Patterns of care and survival among patients with malignant mesothelioma in the United States,” published August 10 in the journal Lung Cancer, aimed to describe the patterns of care and subsequent survival among mesothelioma patients in the U.S. while adjusting for patient demographics and pre-existing health conditions. Using the NCI’s Surveillance, Epidemiology, and End Results (SEER) data, researchers discovered significant differenc...
Source: Asbestos and Mesothelioma News - August 21, 2017 Category: Environmental Health Authors: Matt Mauney Tags: amount of mesothelioma patients eligible for surgery checkpoint inhibitors clinical trial enrollment cytoreduction surgery heated chemotherapy pleural mesothelioma heated intraperitoneal chemotherapy immunotherapy mesothelioma keytruda Lin Source Type: news

Mesothelioma, Asbestos Diseases Costly for Canadians
The annual cost of asbestos-related occupational disease in Canada is estimated at $2.35 billion, according to new findings by a panel of epidemiologists, public health experts and medical professionals. Their estimate is based on direct, indirect and quality-of-life costs related to the 2,331 patients in Canada diagnosed with mesothelioma or asbestos-related lung cancer in 2011. Occupational and Environmental Medicine, a monthly peer-reviewed medical journal, released the updated report in July. It followed a similar study conducted by the same group of experts in 2016. “When you look at the big picture [and] consid...
Source: Asbestos and Mesothelioma News - August 16, 2017 Category: Environmental Health Authors: Matt Mauney Tags: asbestos ban in canada asbestos mines canada asbestosis canada canada mesothelioma Dr. Emile Tompa economic burden asbestos canada financial burden mesothelioma canada health care costs mesothelioma canada House of Commons Occupational a Source Type: news

German Study Finds Novel Chemotherapy Technique Extends Mesothelioma...
Scientists say the key is confining chemotherapy drugs to the chest area, where they can have the most impact on the mesothelioma tumor.(PRWeb August 14, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14597411.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 14, 2017 Category: Pharmaceuticals Source Type: news

Lung-Sparing P/D Surgery Best for Mesothelioma Patients
The latest studies have shown, and most thoracic oncologists agree, that lung-sparing pleurectomy/decortication is a better surgical option for mesothelioma patients today than the more aggressive extrapleural pneumonectomy. Less is better. Quality of life becomes better, too. “In most instances, the pleurectomy/decortication is the operation of choice now,” thoracic surgeon Dr. Andrea Wolf at Mount Sinai Hospital in New York City, told Asbestos.com. “We’re finding that patients just do better in terms of survival and in terms of quality of life.” Wolf recently co-authored “The impact of...
Source: Asbestos and Mesothelioma News - August 9, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Annals of Translational Medicine best surgery for mesothelioma Dr. Andrea Wolf Dr. Hasan Batirel eligible for mesothelioma surgery extrapleural pneumonectomy lung-sparing surgery Marmara University Hospital mesothelioma histology mesothe Source Type: news

Promising Drug Reduces Growth of Aggressive Mesothelioma
Scientists in Italy have found a platinum-based drug that successfully lessens growth of the most aggressive type of mesothelioma cancer cells. Researchers at the University of Salento discovered the experimental drug Ptac2S was more effective in reducing the spread of sarcomatoid malignant pleural mesothelioma cells in mice compared to cisplatin — the most widely used chemotherapy drug for treating mesothelioma. Sarcomatoid is the least common of the three mesothelioma cell types but is considered more aggressive and harder to treat. A diagnosis with the sarcomatoid cell type is typically associated with a poor pro...
Source: Asbestos and Mesothelioma News - August 7, 2017 Category: Environmental Health Authors: Matt Mauney Tags: Alimta alternatives to cisplatin Antonella Muscella Biphasic mesothelioma chemotherapy for mesothelioma chemotherapy resistance DNA adducts epithelioid mesothelioma genomic activities mesothelioma clinical trials mesothelioma survival Source Type: news